Robert Hoffman
2018
In 2018, Robert Hoffman earned a total compensation of $1.7M as Chief Financial Officer and Senior Vice President, Finance at Heron Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,463 |
|---|---|
| Option Awards | $1,139,706 |
| Salary | $357,438 |
| Other | $8,027 |
| Total | $1,719,634 |
Hoffman received $1.1M in option awards, accounting for 66% of the total pay in 2018.
Hoffman also received $214.5K in non-equity incentive plan, $357.4K in salary and $8K in other compensation.
Rankings
In 2018, Robert Hoffman's compensation ranked 6,488th out of 14,244 executives tracked by ExecPay. In other words, Hoffman earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,488 out of 14,244 | 55th |
Division Manufacturing | 2,480 out of 5,765 | 57th |
Major group Chemicals And Allied Products | 922 out of 2,128 | 57th |
Industry group Drugs | 774 out of 1,817 | 57th |
Industry Pharmaceutical Preparations | 602 out of 1,391 | 57th |
Source: SEC filing on April 23, 2020.
Hoffman's colleagues
We found three more compensation records of executives who worked with Robert Hoffman at Heron Therapeutics in 2018.